Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

NCT05492123 2024-01-05

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Phase 2 Recruiting

112 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06149767 2023-11-29

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Phase 2 Not yet recruiting

26 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05325229 2022-10-13

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

Phase 2 Unknown

94 enrolled

Gynecologic

Platinum-resistant Recurrent Ovarian Cancer

NCT05475847 2022-07-28

TIL

Phase 1 Unknown

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02317705 2022-06-21

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Phase 2 Completed

48 enrolled 10 charts

Gynecologic

Ovarian Neoplasms

NCT04812002 2022-06-03

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Phase 2 Recruiting

20 enrolled

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Gestational Trophoblastic Disease

NCT03180307 2022-02-04

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Phase 3 Completed

140 enrolled 11 charts 1 FDA

Gynecologic

Ovarian Neoplasms

NCT04489706 2020-07-28

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Phase NA Unknown

20 enrolled

Gynecologic

Neoplasm Metastasis, Ovarian Neoplasms, Recurrence, Endometrial Neoplasms

NCT02223052 2020-05-12

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Phase 1 Completed

89 enrolled

BreastCNSDermatologicGenitourinaryGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Glioblastoma, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Osteosarcoma, Skin Neoplasms, Testicular Neoplasms, Thyroid Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Small Cell Lung Carcinoma

NCT02233387 2019-03-08

HX4-cervix

Phase 2 Terminated

4 enrolled

Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT03818282 2019-02-26

OC-01

Phase 2 Unknown

77 enrolled

Gynecologic

Ovarian Neoplasms

NCT01673022 2018-07-24

FIRES

Phase NA Completed

430 enrolled 7 charts

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

Clinical Trials

CYTALUX Dose Extension Study

MK-3475-D20

A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer

RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer

A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer

Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer

Study of Paclitaxel Micelles for Injection in Chinese Patients With Advanced Solid Tumors.

A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Exploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis

A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer

IV Contrast-Enhanced Cone Beam Computed Tomography (CBCT) in Radiotherapy

Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma

KEYNOTE F19

Nivolumab-ipilimumab and Chemoradiation for Cervical Cancer

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

A Study of Docetaxel for Injection (Albumin-bound) in Combination With Bevacizumab in Patients With Ovarian Cancer

TIL

Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer

Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

HX4-cervix

OC-01

FIRES